COSMOS Pharmaceutical Corporation (TYO:3349)

Market Cap	503.28B -14.0%
Revenue (ttm)	1.11T +9.0%
Net Income	32.13B +3.6%
EPS	405.34 +3.6%
Shares Out	79.26M
PE Ratio	15.67
Forward PE	15.42
Dividend	84.00 (1.32%)
Ex-Dividend Date	Nov 27, 2026

Volume	602,300
Open	6,501.00
Previous Close	6,324.00
Day's Range	6,321.00 - 6,558.00
52-Week Range	5,615.00 - 8,121.00
Beta	0.16
Analysts	Buy
Price Target	7,510.00 (+18.27%)
Est. Earnings	Jan 8, 2027

About COSMOS Pharmaceutical

COSMOS Pharmaceutical Corporation engages in the retail sale of pharmaceuticals, cosmetics, daily necessities, and food products in Japan. The company offers general medicines, over-the-counter drugs, energy drinks, oral and nursing care products, vitamins, health foods, diet foods, and prescriptions; and cosmetics, men's cosmetics, hair care, and bath additives products. It also provides baby products, detergents, insect repellents, air fresheners, bath and toilet products, cooking supplies, gardening supplies, household and cleaning supplies,...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1983
• Employees: 5,984
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 3349

Financial Performance

In fiscal year 2026, COSMOS Pharmaceutical's revenue was 1.10 trillion, an increase of 8.72% compared to the previous year's 1.01 trillion. Earnings were 32.05 billion, an increase of 3.45%.

Analyst Summary

According to 10 analysts, the average rating for 3349 stock is "Buy." The 12-month stock price target is ¥7,510, which is an increase of 18.27% from the latest price.

Price Target

¥7,510

(18.27% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 23, 2026

Data Sources Report a data error